Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Fibrosis

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

374 public trials 55 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06967805

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: WISPer Site in Birmingham, AL Birmingham, Alabama, United States

WISPer site in Phoenix, AZ Phoenix, Arizona, United States

WISPer Site in Los Angeles, CA Los Angeles, California, United States

WISPer site in Newport Beach, CA Newport Beach, California, United States

View all 69 locations

View Trial Details

Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

NCT00470327

Conditions: Connective Tissue Diseases, Connective Tissue Disorder, Hemic and Lymphatic Diseases, +13 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

NCT07002034

Conditions: Adjustment Disorder, Adjustment Disorders, Amyotrophic Lateral Sclerosis, +28 more
Locations: UAB, Psychiatry and Behavioral Neurology Birmingham, Alabama, United States

University of Arizona Tucson, Arizona, United States

Kadima Neuropsychiatry Institute San Diego, California, United States

Providence Medical Foundation Santa Rosa, California, United States

View all 30 locations

View Trial Details

Recruiting

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

NCT04362644

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Skeletal Muscle Function in Interstitial Lung Disease

NCT03800017

Conditions: Alveolitis, Extrinsic Allergic, Connective Tissue Diseases, Hypersensitivity, +16 more
Locations: St. Paul's Hospital Vancouver, British Columbia, Canada

View Trial Details

Recruiting

A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants

NCT07454291

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Research Site Brisbane, Queensland, Australia

Research Site Melbourne, Victoria, Australia

View Trial Details

Recruiting

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

NCT07447102

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: Dragonboat Biopharmaceutical,Co.,Ltd Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

NCT05842681

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Assiut university-Faculty of Medicine Asyut, Egypt

Faculty of Medicine Assuit University Asyut, Egypt

View Trial Details

Recruiting

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

NCT03297775

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +13 more
Locations: University of Colorado - Anschutz Medical Campus Aurora, Colorado, United States

View Trial Details

Recruiting

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

NCT07082842

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: China-Japan Friendship Hospital Beijing, Beijing Municipality, China

View Trial Details